United States · FDA National Drug Code directory
Irbesartan and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 29300-216_a2e7c9d1-50c4-4a14-8dd5-8dfc6d63a29a
- Product NDC
- 29300-216
- Form
- TABLET, FILM COATED
- Composition / generic term
- Irbesartan and Hydrochlorothiazide
- Labeler
- Unichem Pharmaceuticals (USA), Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170919
- Source listing expiry
- 20261231
Source-listed ingredients
- IRBESARTAN — 300 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-216-10) · 29300-216-10
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-216-13) · 29300-216-13
- 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-216-19) · 29300-216-19
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →